References
Alfaidy, N, Gupta, S, DeMarco, C,
Caniggia, I, & Challis, JRG. (2002). Oxygen regulation of placental
11β-hydroxysteroid dehydrogenase 2: physiological and pathological
implications. The Journal of Clinical Endocrinology & Metabolism,
87 (10), 4797-4805.
Bridgman, J. (1948). A morphological
study of the development of the placenta of the rat; an outline of the
development of the placenta of the white rat. J Morphol, 83 (1),
61-85. doi: 10.1002/jmor.1050830104
Brown, R. W., Chapman, K. E.,
Kotelevtsev, Y., Yau, J. L., Lindsay, R. S., Brett, L.et al. (1996).
Cloning and production of antisera to human placental 11
beta-hydroxysteroid dehydrogenase type 2. Biochem J, 313 ( Pt 3) ,
1007-1017. doi: 10.1042/bj3131007
Burton, P.J., & Waddell, B.J. (1999).
Dual function of 11β-hydroxysteroid dehydrogenase in placenta:
modulating placental glucocorticoid passage and local steroid action.Biology of Reproduction, 60 (2), 234-240.
Causevic, M., & Mohaupt, M. (2007).
11β-Hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia.Molecular aspects of medicine, 28 (2), 220-226.
Chen, H. C. (2005). Boyden chamber
assay. Methods in Molecular Biolology, 294 , 15-22. doi:
10.1385/1-59259-860-9:015
Cotechini, T., Komisarenko, M.,
Sperou, A., Macdonald-Goodfellow, S., Adams, M. A., & Graham, C.H.
(2014). Inflammation in rat pregnancy inhibits spiral artery remodeling
leading to fetal growth restriction and features of preeclampsia.Journal of Experimental Medicine, 211 (1), 165-179.
Cottrell, E. C., Seckl, J. R., Holmes,
M. C., & Wyrwoll, C. S. (2014). Foetal and placental 11beta-HSD2: a hub
for developmental programming. Acta Physiologica (Oxf), 210 (2),
288-295. doi: 10.1111/apha.12187
Duax, W.L, Ghosh, D., & Pletnev, V.
(2000). Steroid dehydrogenase structures, mechanism of action, and
disease. Vitamin & Hormones 58,121-148
Fahlbusch,F.B.,
Ruebner, M., Rascher, W., & Rauh, M. (2013). Combined quantification of
corticotropin-releasing hormone, cortisol-to-cortisone ratio and
progesterone by liquid chromatography–Tandem mass spectrometry in
placental tissue. Steroids, 78 (9), 888-895.
Fahlbusch, F B, Heussner, K, Schmid, M, Schild, R, Ruebner, M, Huebner,
H.et al. (2015) Measurement of amniotic fluid steroids of
midgestation via LC–MS/MS. The Journal of steroid biochemistry
and molecular biology, 152 , 155-160.
Fowden, A.L, & Forhead, A.J. (2015).
Glucocorticoids as regulatory signals during intrauterine development.Experimental physiology, 100 (12), 1477-1487.
Fraser, T. B, Turner, S.W, Mangos,
GJ, Ludbrook, J, & Whitworth, JA. (2001). Comparison of telemetric and
tail‐cuff blood pressure monitoring in adrenocorticotrophic
hormone‐treated rats. Clinical and Experimental Pharmacology and
Physiology, 28 (10), 831-835.
Hofmann M, Pollow K, Bahlmann F, Casper F, Steiner E. & Brockerhoff ,
P. (2001)
11
beta-hydroxysteroid dehydrogenase (11 beta-HSD-II) activity in human
placenta: its relationship to placental weight and birth weight and its
possible role in hypertension. Journal of Perinatal
Medicine, 29(1):23-30. doi: 10.1515/JPM.2001.003.
He, P., Chen, Z., Sun, Q., Li, Y.,
Gu, H., & Ni, X. (2014). Reduced expression of 11beta-hydroxysteroid
dehydrogenase type 2 in preeclamptic placentas is associated with
decreased PPARgamma but increased PPARalpha expression.Endocrinology, 155 (1), 299-309. doi: 10.1210/en.2013-1350
Hodel, M., Blank, P. R., Marty, P.,
& Lapaire, O. (2019). sFlt-1/PlGF Ratio as a Predictive Marker in Women
with Suspected Preeclampsia: An Economic Evaluation from a Swiss
Perspective. Disease Markers, 2019 , 4096847. doi:
10.1155/2019/4096847
Hu, T., Wang, G., Zhu, Z., Huang, Y.,
Gu, H., & Ni, X. (2015). Increased ADAM10 expression in preeclamptic
placentas is associated with decreased expression of hydrogen sulfide
production enzymes. Placenta, 36 (8), 947-950. doi:
10.1016/j.placenta.2015.05.007
Hung, T. H., Chen, S. F., Hsieh, C.
C., Hsu, J. J., Li, M. J., Yeh, Y. L.,et.al. (2008). Tumor necrosis
factor-alpha converting enzyme in the human placenta throughout
gestation. Reproductive Science, 15 (2), 195-209. doi:
10.1177/1933719107310709
Hunter, R.W, & Bailey, M.A. (2015).
Glucocorticoids and 11β-hydroxysteroid dehydrogenases: mechanisms for
hypertension. Current opinion in pharmacology, 21 , 105-114.
Jones JC, Rustagi S, Dempsey PJ. (2016)
ADAM
Proteases and Gastrointestinal Function. Annual Review of Physiology.
78:243-76.
Kisanga, EP, Tang, Z, Guller, S &
Whirledge, S. (2018). Glucocorticoid signaling regulates cell invasion
and migration in the human first‐trimester trophoblast cell line Sw. 71.American Journal of Reproductive Immunology, 80 (1), e12974.
Li, XQ, Zhu, P, Myatt, Leslie, &
Sun, K. (2014). Roles of glucocorticoids in human parturition: a
controversial fact? Placenta, 35 (5), 291-296.
Li, Z., Zhang, Y., Ying Ma, J.,
Kapoun, A. M., Shao, Q., Kerr, I.,et al. (2007). Recombinant vascular
endothelial growth factor 121 attenuates hypertension and improves
kidney damage in a rat model of preeclampsia. Hypertension,
50 (4), 686-692. doi: 10.1161/hypertensionaha.107.092098
Lindsay, R.S, Lindsay, R.M, Edwards,
C.R. & Seckl, J.R. (1996). Inhibition of 11β-hydroxysteroid
dehydrogenase in pregnant rats and the programming of blood pressure in
the offspring. Hypertension, 27 (6), 1200-1204.
Ma, R., Gu, Y., Groome, L. J., &
Wang, Y. (2011). ADAM17 regulates TNFalpha production by placental
trophoblasts. Placenta, 32 (12), 975-980. doi:
10.1016/j.placenta.2011.09.015
Mandl, M, Ghaffari-Tabrizi, N, Haas,
J, Nohammer, G, & Desoye, G. (2006). Differential glucocorticoid
effects on proliferation and invasion of human trophoblast cell lines.Reproduction, 132 (1), 159-167.
Mirazi, N., Alfaidy, N., Martin, R.,
& Challis, J.R.G. (2004). Effects of dexamethasone and sulfasalazine on
prostaglandin E2 output by human placental cells in vitro. Journal
of the Society for Gynecologic Investigation, 11 (1), 22-26.
Murphy, K. E., Willan, A. R., Hannah,
M. E., Ohlsson, A., Kelly, E. N., Matthews, S. G.,et.al. (2012). Effect
of antenatal corticosteroids on fetal growth and gestational age at
birth. Obstetrics and Gynecology, 119 (5), 917-923. doi:
10.1097/AOG.0b013e31825189dc
Patel, F.A, Sun, K.,& Challis,
J.R.G. (1999). Local modulation by 11β-hydroxysteroid dehydrogenase of
glucocorticoid effects on the activity of 15-hydroxyprostaglandin
dehydrogenase in human chorion and placental trophoblast cells.The Journal of Clinical Endocrinology & Metabolism, 84 (2),
395-400.
Pavek, P, Cerveny, L, Svecova, L,
Brysch, M, Libra, A, Vrzal, R, et al. (2007). Examination of
Glucocorticoid receptor α-mediated transcriptional regulation of
P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell
lines. Placenta, 28 (10), 1004-1011.
Peng, B, Zhu, H, Klausen, C., Ma, L.,
Wang, Y.-L., & Leung, P. C.K. (2016). GnRH regulates trophoblast
invasion via RUNX2-mediated MMP2/9 expression. Mhr: Basic science
of reproductive medicine, 22 (2), 119-129.
Renaud, S.J, Cotechini, T., Quirt,
J.S, Macdonald-Goodfellow, S. K, Othman, M., & Graham, C. H. (2011).
Spontaneous pregnancy loss mediated by abnormal maternal inflammation in
rats is linked to deficient uteroplacental perfusion. The Journal
of Immunology, 186 (3), 1799-1808.
Roberts, JM, & Cooper, D. W. (2001).
Pathogenesis and genetics of pre-eclampsia. The Lancet,
357 (9249), 53-56.
Saleh, L., Samantar, R., Garrelds, I.
M., van den Meiracker, A. H., Visser, W., & Danser, A. H. J. (2017).
Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1
Levels in Women With Confirmed or Suspected Preeclampsia Using Proton
Pump Inhibitors. Hypertension, 70 (3), 594-600. doi:
10.1161/hypertensionaha.117.09741
Saleh, L., Verdonk, K., Jan Danser,
A. H., Steegers, E. A., Russcher, H., van den Meiracker, A. H., &
Visser, W. (2016). The sFlt-1/PlGF ratio associates with prolongation
and adverse outcome of pregnancy in women with (suspected) preeclampsia:
analysis of a high-risk cohort. European Journal of Obstetrics,
Gynecology and Reproductive Biology, 199 , 121-126. doi:
10.1016/j.ejogrb.2016.02.013
Sanna, PP, Kawamura, T, Chen, J,
Koob, GF, Roberts, AJ, Vendruscolo, LF, & Repunte-Canonigo, V. (2016).
11β-hydroxysteroid dehydrogenase inhibition as a new potential
therapeutic target for alcohol abuse. Translational psychiatry,
6 (3), e760-e760.
Schoof, E, Girstl, M, Frobenius, W,
Kirschbaum, M, Dorr, HG, Rascher, W, & Dotsch, J. (2001). Decreased
gene expression of 11β-hydroxysteroid dehydrogenase type 2 and
15-hydroxyprostaglandin dehydrogenase in human placenta of patients with
preeclampsia. The Journal of Clinical Endocrinology & Metabolism,
86 (3), 1313-1317.
Seki, H. (2014). Balance of
antiangiogenic and angiogenic factors in the context of the etiology of
preeclampsia. Acta obstetricia et gynecologica Scandinavica,
93 (10), 959-964.
Sibai, B., Dekker, G., & Kupferminc,
M. (2005). Pre-eclampsia. Lancet, 365 (9461), 785-799. doi:
10.1016/s0140-6736(05)17987-2
Stewart, PM, Wallace, AM, Atherden,
SM, Shearing, CH, & Edwards, CRW. (1990). Mineralocorticoid activity of
carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11
β-hydroxysteroid dehydrogenase activity in man. Clinical Science,
78 (1), 49-54.
Strevens, H., Wide‐Swensson, D.,
Grubb, A., Hansen, A., Horn, T., Ingemarsson, I. et. al. (2003). Serum
cystatin C reflects glomerular endotheliosis in normal, hypertensive and
pre‐eclamptic pregnancies. BJOG: An International Journal of
Obstetrics & Gynaecology, 110 (9), 825-830.
Szpera-Gozdziewicz, A. &
Breborowicz, G.H. (2014). Endothelial dysfunction in the pathogenesis of
pre-eclampsia. Front Biosci (Landmark Ed), 19 (1), 734.
Welberg, L. A., Seckl, J. R., &
Holmes, M. C. (2000). Inhibition of 11beta-hydroxysteroid dehydrogenase,
the foeto-placental barrier to maternal glucocorticoids, permanently
programs amygdala GR mRNA expression and anxiety-like behaviour in the
offspring. European Journal of Neuroscience, 12 (3), 1047-1054.
doi: 10.1046/j.1460-9568.2000.00958.x
Yang, Y., Wang, Y., Zeng, X., Ma, X.
J., Zhao, Y., Qiao, J. et. al. (2012). Self-control of HGF regulation on
human trophoblast cell invasion via enhancing c-Met receptor shedding by
ADAM10 and ADAM17. Journal of Clinical Endocrinology and
Metabolism, 97 (8), E1390-1401. doi: 10.1210/jc.2012-1150
Zannas, A.S, & Chrousos, G. P.
(2015). Glucocorticoid signaling drives epigenetic and transcription
factors to induce key regulators of human parturition. Sci.
Signal., 8 (400), fs19-fs19.
Zeisler, H., Llurba, E., Chantraine,
F., Vatish, M., Staff, A.C, Sennström, M.,et al. (2016). Soluble
fms-like tyrosine kinase-1-to-placental growth factor ratio and time to
delivery in women with suspected preeclampsia. Obstetrics &
Gynecology, 128 (2), 261-269.
Zha, Y. P., Wang, Y. K., Deng, Y.,
Zhang, R. W., Tan, X., Yuan, W. J., et al. (2013). Exercise training
lowers the enhanced tonically active glutamatergic input to the rostral
ventrolateral medulla in hypertensive rats. CNS Neurosci Ther,
19 (4), 244-251. doi: 10.1111/cns.12065
Zhang, B., Tan, L., Yu, Y., Wang, B.,
Chen, Z., Han, J., et al. (2018). Placenta-specific drug delivery by
trophoblast-targeted nanoparticles in mice. Theranostics, 8 (10),
2765-2781. doi: 10.7150/thno.22904
Zhang, H., Hou, L., Li, C. M., &
Zhang, W. Y. (2013). The chemokine CXCL6 restricts human trophoblast
cell migration and invasion by suppressing MMP-2 activity in the first
trimester. Hum Reprod, 28 (9), 2350-2362. doi:
10.1093/humrep/det258
Zhao, S., Gu, Y., Fan, R., Groome, L.
J., Cooper, D., & Wang, Y. (2010). Proteases and sFlt-1 release in the
human placenta. Placenta, 31 (6), 512-518. doi:
10.1016/j.placenta.2010.03.014
Zunke,F.,Rose-John, S (2017). The Shedding Protease ADAM17: Physiology
and Pathophysiology. Biochimica et biophysica acta. Molecular cell
research. 1864 (11 Pt B), 2059-2070